BIONTECH SE (BNTX)
Clinical trial NCT07730450 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. completion date: 2027-08-06 → 2027-08-20 3. primary completion date: 2027-08-06 → 2027-08-20 4. masking: DOUBLE → NONE
Clinical trial NCT07730450 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. completion date: 2027-08-06 → 2027-08-20 3. primary completion date: 2027-08-06 → 2027-08-20 4. masking: DOUBLE → NONE
Clinical trial NCT05502393 updates: 1. status: UNKNOWN → ACTIVE_NOT_RECRUITING 2. completion date: 2024-12-31 → 2027-12-31 3. primary completion date: 2024-07-31 → 2027-12-31 4. enrollment: 118 → 133 participants 5. enrollment type: ESTIMATED → ACTUAL 6. allocation: NA → NON_RANDOMIZED 7. masking: NONE → SINGLE
Clinical trial NCT07498335: status: NOT_YET_RECRUITING → RECRUITING.
Clinical trial NCT06577363 updates: 1. completion date: 2031-08-30 → 2028-06-30 2. primary completion date: 2031-08-30 → 2028-06-30
Clinical trial NCT04280081: completion date: 2027-11-01 → 2028-11-01.
Financial Statements and Related Announcement: Profit Guidance
Clinical trial NCT03408314: enrollment: 196 → 194 participants.
Clinical trial NCT05509569 updates: 1. completion date: 2026-05-29 → 2026-07-17 2. primary completion date: 2026-05-29 → 2026-07-17
Clinical trial NCT06958315: enrollment: 198 → 219 participants.
Clinical trial NCT07550517 updates: 1. start date: 2026-07-01 → 2026-08-01 2. completion date: 2033-07-01 → 2033-08-01 3. primary completion date: 2032-07-01 → 2032-08-01